$72.98 0.5%
GMED Stock Price vs. AI Score
Data gathered: April 15

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Globus Medical (GMED)

Analysis generated January 4, 2024. Powered by Chat GPT.

Globus Medical is a leading medical device company focused on developing products that promote healing in patients with musculoskeletal disorders. The company specializes in spine and orthopedic implants and surgical instruments, aiming to improve patient care and outcomes through innovative design and technologies. With a commitment to research and development, Globus Medical has established itself as a key player in the spine market and has been expanding its reach to other areas within orthopedics.

Read full AI stock Analysis

Stock Alerts - Globus Medical (GMED)

company logo Globus Medical | April 10
Price is down by -5.1% in the last 24h.
company logo Globus Medical | April 9
Price is up by 5.5% in the last 24h.
company logo Globus Medical | April 4
News Alert: Globus Medical completes acquisition of Nevro Corp.
company logo Globus Medical | April 4
Price is down by -5.3% in the last 24h.

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.


Globus Medical
Price $72.98
Target Price Sign up
Volume 944,290
Market Cap $9.98B
Year Range $67.08 - $93.32
Dividend Yield 0%
PE Ratio 96.79
Analyst Rating 71% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24626M544M82M52M78M0.830
Q2 '24630M260M370M32M77M0.750
Q1 '24607M241M365M-7.1M21M0.720
Q4 '23617M265M351M15M54M0.600
Q3 '23384M135M248M1,000,00016M0.570

Insider Transactions View All

RHOADS ANN D filed to sell 35,384 shares at $78.7.
March 4 '25
Pfeil Keith W filed to sell 1,666 shares at $88.2.
January 14 '25

What is the Market Cap of Globus Medical?

The Market Cap of Globus Medical is $9.98B.

What is Globus Medical's PE Ratio?

As of today, Globus Medical's PE (Price to Earnings) ratio is 96.79.

What is the current stock price of Globus Medical?

Currently, the price of one share of Globus Medical stock is $72.98.

How can I analyze the GMED stock price chart for investment decisions?

The GMED stock price chart above provides a comprehensive visual representation of Globus Medical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Globus Medical shares. Our platform offers an up-to-date GMED stock price chart, along with technical data analysis and alternative data insights.

Does GMED offer dividends to its shareholders?

As of our latest update, Globus Medical (GMED) does not offer dividends to its shareholders. Investors interested in Globus Medical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Globus Medical?

Some of the similar stocks of Globus Medical are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.